⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
businesswire.com
AZN
DAI
MRK
Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare
prnewswire.com
JNJ
ABBV
VRTX
AZN
INCY
BIIB
NVS
ROG
PFE
BMY
8MM Respiratory Syncytial Virus Prophylaxis Drug Forecast Report 2025: A $7.2 Billion Market by 2030, Prophylactic Options to Continue to Diversify Due to Strength of Late-stage Pipeline
globenewswire.com
AZN
ABBV
SNY
MRK
GSK
PFE
MRNA
Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035
globenewswire.com
MRK
AZN
CRSP
BGNE
NKTR
ALKS
XNNY
BMY
Inhaled Therapy in Respiratory Disease Market to Grow USD 16.22 Billion by 2034
globenewswire.com
GSK
AZN
TEVA
BMY
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
globenewswire.com
PFE
AZN
DSNKY
GILD
IMMU
REGN
BIIB
BMY
MRK
NVS
AMGN
LLY
JNJ
ABBV
BNTX
SEGN
RHHBY
Takeda
IQV
PE
Metered Dose Inhalers Market to Reach $18.4 billion, Globally, by 2034 at 6.2% CAGR: Allied Market Research
prnewswire.com
TEVA
AZN
VTRS
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
globenewswire.com
HCM
LLY
AZN
Myasthenia Gravis Market Intelligence 2025-2035: Expansion Into Emerging Markets with Unmet Medical Needs Presents Lucrative Opportunities
globenewswire.com
ARGO
JNJ
AZN
DNA Damaging Agents Market Grows at 11.67% CAGR, to Hit USD 46.31 Billion by 2034
globenewswire.com
XRAY
NVS
RUC
NIRA
TLZ
AZN
BMY
MRK